M. Inci Et Al. , "Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report," Annual Meeting of the American-Academy-of-Neurology , vol.94, Toronto, Canada, 2020
Inci, M. Et Al. 2020. Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report. Annual Meeting of the American-Academy-of-Neurology , (Toronto, Canada).
Inci, M., Gunduz, T., Kurtuncu, M., & Eraksoy, M., (2020). Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report . Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada
Inci, Meltem Et Al. "Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report," Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 2020
Inci, Meltem Et Al. "Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report." Annual Meeting of the American-Academy-of-Neurology , Toronto, Canada, 2020
Inci, M. Et Al. (2020) . "Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report." Annual Meeting of the American-Academy-of-Neurology , Toronto, Canada.
@conferencepaper{conferencepaper, author={Meltem Inci Et Al. }, title={Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report}, congress name={Annual Meeting of the American-Academy-of-Neurology}, city={Toronto}, country={Canada}, year={2020}}